PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Immunology and Genomic Medicine, National Jewish Health, Denver, CO, USA.\', \'Department of Immunology and Microbiology, School of Medicine, Anschutz Medical Center, University of Colorado, Aurora, CO, USA.\', \'State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agriculture University, Beijing, People\'s Republic of China.\', \'Department of Nursing, National Jewish Health, Denver, CO, USA.\', \'Department of Pharmacy, National Jewish Health, Denver, CO, USA.\', \'Department of Medicine, National Jewish Health, Denver, CO, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/19420862.2021.1919285
?:hasPublicationType
?:journal
  • mAbs
is ?:pmid of
?:pmid
?:pmid
  • 34074219
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.236
?:rankingScore_hIndex
  • 57
?:title
  • 501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34074219>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34074219>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all